Skip to content
10-Q

Quarterly Report

STEMLINE THERAPEUTICS INC

0001104659-19-028623

← back to feed
Filed
May 10, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · May 9, 2019 43.68M sh
Short Term Investments Q1 2019 · Mar 31, 2019 $100.34M
Short Term Investments Q1 2019 · Dec 31, 2018 $50.66M
Cash And Equivalents Q1 2019 · Mar 31, 2019 $24.01M
Cash And Equivalents Q1 2019 · Dec 31, 2018 $9.44M
Current Liabilities Q1 2019 · Mar 31, 2019 $26.44M
Current Liabilities Q1 2019 · Dec 31, 2018 $21.22M
Total Liabilities Q1 2019 · Mar 31, 2019 $27.27M
Total Liabilities Q1 2019 · Dec 31, 2018 $21.29M
Current Assets Q1 2019 · Mar 31, 2019 $133.94M
Current Assets Q1 2019 · Dec 31, 2018 $63.06M
Total Assets Q1 2019 · Mar 31, 2019 $136.17M
Total Assets Q1 2019 · Dec 31, 2018 $63.49M
Net Income Q1 2019 · Mar 31, 2019 −$328.2M
Net Income Q1 2019 · Mar 31, 2018 −$18.42M
Operating Cash Flow Q1 2019 · Mar 31, 2018 −$17.09M
Stockholders Equity Q1 2019 · Mar 31, 2018 $88.02M
Stockholders Equity Q1 2019 · Dec 31, 2017 $47.07M
Sga Expense Q1 2019 · Mar 31, 2018 $5.94M
Rd Expense Q1 2019 · Mar 31, 2018 $12.71M
Operating Income Q1 2019 · Mar 31, 2018 −$18.65M